ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 132 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $491,791 | -56.9% | 24,516 | -39.4% | 0.01% | -60.0% |
| Q2 2023 | $1,141,320 | +187.4% | 40,458 | +75.2% | 0.03% | +172.7% |
| Q1 2023 | $397,096 | +93.7% | 23,087 | +216.3% | 0.01% | +22.2% |
| Q2 2022 | $205,000 | -25.7% | 7,298 | +22.1% | 0.01% | -30.8% |
| Q1 2022 | $276,000 | -78.2% | 5,975 | -60.3% | 0.01% | -83.3% |
| Q4 2021 | $1,266,000 | +298.1% | 15,061 | +152.3% | 0.08% | +188.9% |
| Q2 2021 | $318,000 | -9.9% | 5,969 | -12.2% | 0.03% | -27.0% |
| Q4 2020 | $353,000 | – | 6,798 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Decheng Capital Management III (Cayman), LLC | 1,824,583 | $39,520,000 | 14.33% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,301,771 | $49,857,000 | 4.79% |
| Matrix Capital Management Company, LP | 9,199,973 | $199,271,000 | 3.81% |
| Integral Health Asset Management, LLC | 550,000 | $11,913,000 | 2.31% |
| Avidity Partners Management LP | 4,223,100 | $91,472,000 | 1.86% |
| Affinity Asset Advisors, LLC | 170,000 | $3,682,000 | 1.03% |
| Eventide Asset Management | 1,861,000 | $40,309,000 | 0.79% |
| Sofinnova Investments, Inc. | 583,357 | $12,636,000 | 0.74% |
| Nicholas Investment Partners, LP | 158,704 | $3,438,000 | 0.32% |
| SECTORAL ASSET MANAGEMENT INC | 60,000 | $1,300,000 | 0.26% |